Proctozone-b Tablet, Coated
Product Images NDC 57237-372

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Proctozone-b (NDC 57237-372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Proctozone-b-container Label-front (Proctozone B Container Label Front)

The label for Proctozone-B Bisacodyl Tablets, USP 5 mg, stimulant laxative, oral dosage form. The label highlights it as an overnight laxative with relief in 6-12 hours. It contains 100 enteric-coated tablets and is distributed by Rising Pharma Holdings, Inc. The label compares the product to Dulcolax and includes a Drug Facts panel with active ingredient, uses, and warnings.*

FDA Label Image

Proctozone-b-container Label-back (Proctozone B Container Label Back)

This Drug Facts panel continues with warnings and directions for Proctozone-B Bisacodyl 5 mg coated tablets. It advises on when to stop use and consult a doctor, precautions for pregnant or breastfeeding individuals, directions for use by different age groups, and storage instructions. The inactive ingredients are listed, and a safety seal warning advises not to use if the seal under the cap is broken or missing. A contact number for questions or comments is provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.